Literature DB >> 23413136

Herpes simplex virus infection and erectile dysfunction: a nationwide population-based study.

C-C Huang1, W-L Chan, Y-C Chen, T-J Chen, C-M Chung, P-H Huang, S-J Lin, J-W Chen, H-B Leu.   

Abstract

Both erectile dysfunction (ED) and herpes simplex virus (HSV) infections are related to cardiovascular events. However, the relationship between ED and HSV infections remains undetermined. The aim of our study was to investigate the possible influence of HSV infections on the development of ED using the Taiwan National Health Insurance database. We identified patients with HSV type 1 or type 2 infections from the 1 000 000 sampling cohort data set. Male patients of age 18 years or older who had been diagnosed as cases of HSV infection since January 1, 2001 were enroled. Patients with previous history of stroke, spinal cord injury or malignancy were excluded. A control group was selected, comprising male patients without HSV infection, stroke, spinal cord injury or malignancy. The age, time of enrolment and comorbidities were matched in the two groups. A total of 1 717 HSV subjects (mean age 43.29 ± 15.97 years) and 6 864 control subjects were enroled. During an average of 3.91 ± 1.93 years' follow-up, HSV-infected subjects experienced a higher incidence of ED than control subjects (1.7% vs. 0.7%, respectively). The log-rank test showed that patients with HSV infections had a significantly higher incidence of ED than those without HSV infections (p < 0.001). After Cox proportional hazard regression model analysis, HSV infections were independently associated with the increased risk of ED (hazard ratio, 2.90; 95% CI, 1.82-4.63, p < 0.001). In conclusion, HSV infections were associated with risk of ED in this cohort.
© 2012 American Society of Andrology and European Academy of Andrology.

Entities:  

Mesh:

Year:  2012        PMID: 23413136     DOI: 10.1111/j.2047-2927.2012.00037.x

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  5 in total

1.  Statin therapy and herpes virus reactivation-response to Zuin et al. paper.

Authors:  Jonathan E Sutton; Negar Maghsoodi; Alexa R Shipman; Kate E Shipman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-05-01       Impact factor: 3.267

Review 2.  [Dermatological diseases and sexuality. How to proceed?].

Authors:  F-M Köhn; H-C Schuppe; K M Beier
Journal:  Hautarzt       Date:  2015-12       Impact factor: 0.751

3.  Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan.

Authors:  Nian-Sheng Tzeng; Chi-Hsiang Chung; Fu-Huang Lin; Chien-Ping Chiang; Chin-Bin Yeh; San-Yuan Huang; Ru-Band Lu; Hsin-An Chang; Yu-Chen Kao; Hui-Wen Yeh; Wei-Shan Chiang; Yu-Ching Chou; Chang-Huei Tsao; Yung-Fu Wu; Wu-Chien Chien
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

4.  Sexual function and sexual quality of life in men with genital warts: a cross-sectional study.

Authors:  Marzieh Hosseini Nia; Fatemeh Rahmanian; Mehdi Ghahartars; Roksana Janghorban
Journal:  Reprod Health       Date:  2022-04-27       Impact factor: 3.355

5.  Erectile Dysfunction in Patients with Sleep Apnea--A Nationwide Population-Based Study.

Authors:  Chia-Min Chen; Ming-Ju Tsai; Po-Ju Wei; Yu-Chung Su; Chih-Jen Yang; Meng-Ni Wu; Chung-Yao Hsu; Shang-Jyh Hwang; Inn-Wen Chong; Ming-Shyan Huang
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.